Anebulo Pharmaceuticals, Inc. SEC filings ANEB
Anebulo Pharmaceuticals, Inc. has 204 filings in SEC EDGAR's recent list, going back to Jun 25, 2020. Its latest annual report, Form 10-K, was filed on Sep 29, 2025 for the period ended Jun 30, 2025. The latest quarterly report (Form 10-Q) was filed on Feb 12, 2026, covering the quarter ended Dec 31, 2025. The most recent current report (Form 8-K) was filed on Feb 12, 2026 (results of operations). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Feb 12, 2026 | Feb 12, 2026 |
| 8-K |
Current report
Listing notice, Other events
|
Feb 6, 2026 | Feb 5, 2026 |
| 8-K |
Current report
Other events
|
Jan 29, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Other events
|
Jan 27, 2026 | Jan 26, 2026 |
| 8-K |
Current report
Other events
|
Dec 22, 2025 | Dec 22, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Results of operations
|
Sep 29, 2025 | Sep 29, 2025 |
| 8-K |
Current report
Other events
|
Sep 12, 2025 | Sep 12, 2025 |
| 8-K |
Current report
Other events
|
Jul 23, 2025 | Jul 23, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Other events
|
Apr 15, 2025 | Apr 11, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 14, 2025 | Apr 11, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Apr 7, 2025 | Apr 4, 2025 |
| 8-K |
Current report
Material agreement, Listing notice
|
Feb 24, 2025 | Feb 20, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 14, 2025 | Feb 14, 2025 |
| 8-K |
Current report
Other events
|
Feb 12, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change in control, Other events
|
Dec 23, 2024 | Dec 22, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 17, 2024 | Oct 17, 2024 |
| 8-K |
Current report
Results of operations
|
Sep 25, 2024 | Sep 25, 2024 |
| 8-K |
Current report
Other events
|
Jul 22, 2024 | Jul 22, 2024 |
| 8-K |
Current report
Other events
|
Jun 17, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Nov 21, 2023 | Nov 20, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 6, 2023 | Oct 5, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 29, 2023 | Sep 26, 2023 |
| 8-K |
Current report
Results of operations
|
Sep 20, 2023 | Sep 20, 2023 |
| 8-K |
Current report
Agreement ended, Officer or director change
|
Sep 5, 2023 | Aug 29, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Other events
|
Apr 11, 2023 | Apr 11, 2023 |
| 8-K |
Current report
Other events
|
Mar 28, 2023 | Mar 28, 2023 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Mar 8, 2023 | Mar 2, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 10, 2023 | Feb 10, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Oct 28, 2022 | Oct 28, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 13, 2022 | Oct 11, 2022 |
| 8-K |
Current report
Unregistered share sale
|
Sep 29, 2022 | Sep 25, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 26, 2022 | Sep 26, 2022 |
| 8-K |
Current report
Results of operations
|
Sep 9, 2022 | Sep 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 5, 2022 | Jul 5, 2022 |
| 8-K |
Current report
Officer or director change
|
May 24, 2022 | May 24, 2022 |
| 8-K |
Current report
Results of operations
|
May 11, 2022 | May 11, 2022 |
| 8-K |
Current report
Other events
|
Apr 1, 2022 | Apr 1, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2022 | Feb 11, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 5, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Other events
|
Jan 3, 2022 | Jan 3, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Nov 16, 2021 | Oct 22, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2021 | Nov 12, 2021 |
| 8-K |
Current report
Results of operations
|
Sep 22, 2021 | Sep 22, 2021 |
Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANEB (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Lakeway, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1815974
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.